Page 23 - P4403.14-V111 December OTC Magazine 2025 NI_Neat

COUGH AND COLD 23

No.1 Up Off

Save

To7%

PHARMACY Trade

RECOMMENDED

SORE THROAT SPRAY i

Buying Trade
Product Size Price/ RRP Offer POR Pip
Single % % Code
DIFFLAM
Difflam Sore Throat Rinse 200ml £4.67 £8.99 7% 38% 2240398
Difflam Oral Rinse 300ml £6.50 £11.19 30% 485896
Difflam Spray 30ml 30ml £4.60 £8.49 3% 35% 349472

Difflam™ Sore Throat Rinses and Lozenges also available.

i Data on file. Pharmacy market research. 203 Pharmacists. April 2025. For verifictaion please email info@difflam.co.uk.
Difflam TM Spray (Benzydamine Hydrochloride 0.15%w/v). Indications: Difflam TM Spray is locally acting analgesic and anti-inflammatory treatment
for the throat and mouth. It is especially useful for the relief of pain in traumatic conditions such as following surgical removal of tonsils, the use of
naso-gastric tube or dental surgery. Legal category: P. Information about this product, including adverse reactions, precautions, contraindications
and method of use can be found at: https://mhraproducts4853.blob.core.windows.net/docs/ab8cded8ef4edc1aa3ff6862d6457b0a85c4cfbd
Difflam™ Sore Throat Rinse (benzydamine hydrochloride 0.15% w/v) & Difflam™ Oral Rinse (benzydamine hydrochloride 0.15% w/v).
Indications: Locally acting analgesic and anti-inflammatory treatment for the relief of inflammatory conditions of the throat including
pharyngitis. Legal category: P. Information about this product, including adverse reactions, precautions, contraindications and method of
be found at: https://www.medicines.org.uk/emc/product/9258/smpc & https://https://mhraproducts4853.blob.core.windows.net/docs/
c3ac96e2bbc807f0659dd78dade71a3cb4f368cd
Difflam™ 3 mg Lozenges (benzydamine hydrochloride) Lemon and Orange-Honey. Indications: Difflam™ lozenges is used and children above 6
years of age for symptomatic local treatment for the relief of pain and irritation of the mouth and throat. Legal category: P. Information about
this product, including adverse reactions, precautions, contraindications and method of use can be found at: https://mhraproducts4853.blob.core.
windows.net/docs/ec8a7f89fdcdc398a6d74f1ba0ac8cd8b284ca01 Date of preparation: August 2025
Marketing Authorisation Holder: Cooper Consumer Health B.V. Verrijn Stuartweg 60, 1112AX Diemen – The Netherlands Ref number: MAT-DIF-00095

04/11/2025 16:42:20
P4403.14-V111 December OTC Magazine 2025 NI.indd 23 04/11/2025 16:42:20
P4403.14-V111 December OTC Magazine 2025 NI.indd 23